4th Quarter - Report

ARENTFOX SCHIFF LLP for ORGANOGENESIS INC.

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products (CY2026) Hospital Outpatient Prospective Payment System regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 5304 and S. 2587 (Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations Act, 2026), regarding reimbursement for chronic wound healing products

LobbyistCovered position, as disclosed
BYRON DORGAN —
KELSEY GRISWOLD-BERGER —
DAN RENBERG —
OLIVER SPURGEON III —
BLAKE THELANDER —

Contacted: HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); SENATE; Executive Office of the President (EOP)

Bills named: S. 2561 (119th), H.R. 5768 (119th), H.R. 5304 (119th), S. 2587 (119th)

Health Issues HCR

Food and Drug Administration policy on chronic wound healing products

LobbyistCovered position, as disclosed
DAN RENBERG —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.